CROSS-BORDER PAYMENTS

Ripple Labs

+22.8%

Strong Asia distribution footprint

Market example only. 3-month price appreciation reflects secondary market transaction data, Q3 2026. Not a confirmed Oper8 Capital platform listing.

Category profile

Series C+

Stage

24–36mo

IPO pathway

Direct

Structure